Chart. Anuh Pharma 3. Do you want to find out the Price to Book ratio history of SUN PHARMACEUTICAL INDUSTRIES and compare it with industry peers of SUN PHARMACEUTICAL INDUSTRIES . This website uses cookies to improve your experience while you navigate through the website. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. Sep 19, 2022. Current ratio = current assets/current liabilities Where according to the company's balance sheets: Current assets: cash, accounts receivable, inventory, and other assets that the company plans to liquidate or convert to cash within the next one year. Dollars. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. | irritability crossword clue. Cash Ratio 23 . TEVA Current Ratio as of today (June 12, 2022) is 1.07. This pharmaceutical giant was founded in 1876. El Paso Saddlery Military, In 2020, North Americas pharmaceutical market accounted for more than 49% of the worlds pharmaceutical sales. The company should find a good balance between enough compensation for the hard work of the officers and having enough working capital for the company to grow at a steady rate. ISIN: | SECTOR: Hospitals & Medical ServicesHospitals & Medical Services, Buy Healthcare Global Enterprises; target of Rs 310: Edelweiss, Narayana Hrudayalaya to acquire 100% stake in NewRise Healthcare, Poly Medicure: Outcome of committee meeting, Fortis Malar Hospitals' unsecured creditors meeting on April 26, 2017, Fortis Healthcare Q3 net profit at Rs 453.29 cr, Apollo Hospitals Q3 net dips 40% to Rs 73 cr, Poly Medicure gains 12%, to consider bonus issue on February 6, Fortis Healthcare Q2 net profit dips 37% to Rs 38 cr, Fortis Q3 PAT may dip 2.1% to Rs 42.8 cr: ICICI Securities, Apollo Hospitals Q1 PAT seen down 8.8% to Rs 69 cr: Edelweiss, Apollo Hospital Q2 profit may rise 7% to Rs 92.87 cr: Poll, Apollo Hospitals Q1 PAT may rise 9% to Rs 76 cr: Poll, Hits & misses in Q3: Rajesh Jain analyses 4 stocks. Cleveland Browns Scouting Jobs, These cookies ensure basic functionalities and security features of the website, anonymously. Do you want to find out the Price to Earnings (PE) ratio history of SUN PHARMACEUTICAL INDUSTRIES and compare it with industry peers of SUN PHARMACEUTICAL INDUSTRIES . Check your inbox or spam folder to confirm your subscription. calibrated vs uncalibrated radiocarbon dates Menu Financial Ratio Search Stocks. Successfully managing debt obligations is a major factor in the long-term viability and profitability of any pharmaceutical company. This ratio also helps to compare various companies in the same sector. Sunpharma has recorded thei highest current ratio in 2011. Europe generated around 228 billion U.S. Note, Numbers include only companies who have reported earnings results. Interest coverage ratio The 5 companies analysed include: 1. Essay, Pages 8 (1901 words) Views. This ratio will vary with industry based on the measure of their fixed assets. Browse . Compare PFE With Other Stocks. Teva Pharmaceutical Industries current ratio for the three months ending December 31, 2022 was. The quick ratio is a good indicator of a company's ability to effectively cover its day-to-day operating expenses. Ranking, Revenue per Employee Statistics as of 4 Q 2022, Revenue per Employee Industry Ranking in the 4 Q 2022, Net Income per Employee Statistics as of 4 Q 2022, Net Income per Employee Industry Ranking in the 4 Q 2022, Receivable Turnover Ratio Statistics as of 4 Q 2022, Receivable Turnover Ratio Industry Ranking in the 4 Q 2022, Inventory Turnover Ratio Statistics as of 4 Q 2022, Inventory Turnover Ratio Industry Ranking in the 4 Q 2022, Inventory Turnover Ratio COS Statistics as of 4 Q 2022, Inventory Turnover Ratio Industry COS Ranking in the 4 Q 2022, Asset Turnover Ratio Statistics as of 4 Q 2022, Asset Turnover Ratio Industry Ranking in the 4 Q 2022. Within Healthcare sector only one Industry has accomplished higher Quick Ratio. The digital revolution can be a boon for the pharmaceutical industry by using disruptive technology such as 3D printed drugs, artificial Intelligence guided therapies, and preventative medicine. 2023 Eqvista Inc. All Rights Reserved. Once a pharma product reaches the marketplace, the company must determine how high a price the company can charge for a drug to earn a profitable return on its investment in the shortest amount of time. Return On Tangible Equity. However, this ratio has to be analyzed over a period of time to understand trends and in comparison with industry benchmarks. The Current P/S Ratio of SUN PHARMACEUTICAL INDUSTRIES is 5.47. Table of Content 1. dos hermanos north market menu. The Current P/E Ratio of SUN PHARMACEUTICAL INDUSTRIES is 53.95. Creditors use this ratio as an indicator to measure a companys creditworthiness. Calculation: Current Assets / Current Liabilities. Gland Pharmas new product play for FY22 holds a lot of promise. For example, a quick ratio of 1.7 indicates that the company has $1.70 liquid assets available for every $1 of their current liabilities. A faulty business valuation can deprive the company of its much needed investments and distort their growth metrics. Company Valuation A company with such a low interest coverage ratio might not be in a position to pay their debt very soon. The size of the firm positively but moderately governs the solvency of the Indian pharmaceutical firms (Ali, 2020c). This comprehensive list of financial ratios by industry was gathered by public tax return data provided by the IRS. Europes top high-tech industry employers are the research-based pharmaceutical industries. Interpretation: In this all companies havent maintained the ideal current ratio, while the highest ratio is 3.89 of Lupin in the year 2015 while the 3.45 in the 2014. This ratio, also known as the debtors turnover ratio, is an efficiency ratio that indicates the companys ability in collecting revenue from its customers. ! Our expert team of analysts at Eqvista can support you through this process. Research expert covering health, pharma & medtech, Top 100 health & pharmaceutical companies. CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. That being said, how good a current ratio is depends on the type of company youre talking about. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. 10,000, Unlocking opportunities in Metal and Mining, Standard Medical Pharmaceuticals Stock Price, Key Financial Ratios of Standard Medical Pharmaceuticals, Book Value [ExclRevalReserve]/Share (Rs. A value of 1 indicates a normal quick ratio. | We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. The working capital turnover indicates how well a company is using its working capital to support sales. The performance of a business is ultimately reflected in their periodic financial statements. With revenue increase of 4.27% in 4 Q 2022 year on year, revenue per employee for Biotechnology & Pharmaceuticals Industry grew on trailing twelve months basis to 997,180 $, above Biotechnology & Pharmaceuticals Industry average. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. Global revenues from the pharmaceutical industry total 1.2 trillion dollars. . As we observed in the previous section, the IRS financial ratio database is the most reliable reference point. The accounts receivables ratio indicates the total number of times a company manages to collect its average accounts receivable balance from its customers in a year. Reproduction of news articles, photos, videos or any other content in whole or in part in any form Browse . You can calculate it using the turnover ratio formula: We are happy to help you with everything and also offer free training. The best of the best: the portal for top lists & rankings: Strategy and business building for the data-driven economy: Pharmaceutical market: worldwide revenue 2001-2022, Global pharmaceutical market - revenue distribution 2010-2021, by region, Top therapeutic classes by global pharmaceutical sales 2018 estimates, Total global pharmaceutical R&D spending 2014-2028, Number of novel drugs approved annually by CDER 2008-2022, Revenue of the worldwide pharmaceutical market from 2001 to 2022 (in billion U.S. dollars), World pharmaceutical sales 2017-2021 by region, Global pharmaceutical sales from 2017 to 2021, by region* (in billion U.S. dollars), World pharmaceutical market distribution by submarket 2014-2021, Distribution of the total global pharmaceutical market sales from 2014 to 2021, by submarket*, Revenues of top 10 global pharmaceutical markets 2021, Revenues of top 10 national pharmaceutical markets worldwide in 2021 (in billion U.S. dollars), Top pharmaceutical products by sales worldwide 2021, Leading pharmaceutical products by sales worldwide in 2021 (in billion U.S. dollars), Share of pharmaceutical value worldwide 2021, by country, Value share of the pharmaceutical market worldwide as of November 2021, by country*, Value share of pharmaceutical subsectors worldwide 2003 vs. 2021, Value share of the pharmaceutical market worldwide in 2003 and 2021, by subsector*, Top therapy classes by spending global market 2026 forecast, Projected top therapy areas worldwide in 2026, by spending (in billion U.S. dollars), Global pharmaceutical revenue by technology 2012-2026, Global pharmaceutical revenue distributed by technology from 2012 to 2026 (in billion U.S. dollars), Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026, Prescription drugs sales worldwide excluding generics and orphan drugs from 2012 to 2026 (in billion U.S. dollars), Projection of global revenue for orphan prescription drugs 2012-2026, Global prescription orphan drug sales from 2012 to 2026 (in billion U.S. dollars), Worldwide generic prescription drug sales 2012-2026, Worldwide generic prescription drug sales from 2012 to 2026 (in billion U.S. dollars), Revenue of the global OTC pharmaceutical market 2016-2027, Revenue of the global OTC pharmaceutical market from 2016 to 2027 (in billion U.S. dollars), Global oncology spending from 2011 to 2023 (in billion U.S. dollars), Tota pharmaceutical value worldwide 2021, by subsector, Total pharmaceutical value worldwide as of November 2021, by subsector* (in million U.S. dollars), Top 50 pharmaceutical companies - Rx sales and R&D spending 2021, Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2021 (in billion U.S. dollars), Global Rx drug market share by top companies 2019 and 2026, Top 20 pharmaceutical companies worldwide based on prescription drug market share in 2019 and 2026*, Top 10 biotech and pharmaceutical companies based on market cap 2022, Leading 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2022 (in billion U.S. dollars), Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars), Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars), Total sales of the Roche Group from 2006 to 2022 (in million Swiss francs), Johnson & Johnson's total sales 2005-2022, Johnson & Johnson's total sales from 2005 to 2022 (in million U.S. dollars), Projected top pharmaceutical companies based on new sales 2023, Leading pharmaceutical companies worldwide based on projected sales increase during 2023 (in billion U.S. dollars), Total global spending on pharmaceutical research and development from 2014 to 2028 (in billion U.S. dollars), Global top pharmaceutical companies based on R&D spending 2026, Global top 10 pharmaceutical companies based on projected R&D spending in 2026 (in billion U.S. dollars), Patent expiration risks for total worldwide prescription drug revenue 2020-2028, Worldwide total prescription drug revenue at risk from patent expiration from 2020 to 2028 (in billion U.S. dollars), Worldwide prescription drug revenue - market risk from patent expiration 2020-2028, Share of global prescription drug revenue at risk from patent expiration from 2020 to 2028, Pharmaceutical industry - number of new substances 1998-2021, Number of new chemical or biological entities developed between 1998 and 2021, by region of origin, Pharma companies worldwide with active R&D pipelines 2001-2022, Total number of pharmaceutical companies with active R&D pipelines worldwide from 2001 to 2022, Total number of novel drugs approved by CDER from 2008 to 2022, Projected most valuable R&D projects based on net present value 2022, Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2022 (in billion U.S. dollars), World pharmaceutical sales by region forecast 2025, Projected global pharmaceutical sales for 2025, by region* (in billion U.S. dollars), Global spending on medicines in 2010, 2021, and a forecast for 2026 (in billion U.S. dollars), CAGR by product type in pharmaceutical markets forecast 2022-2026, Projected pharmaceutical spending CAGR worldwide between 2022 and 2026, by market and product type, Country comparison in spending on medicine 2026, Projected spending on medicine of selected countries worldwide in 2026 (in billion U.S. dollars), Leading global pharmaceutical products by projected sales 2026, Projected top 10 global pharmaceutical products by sales in 2026 (in million U.S. dollars), Top global biopharma drugs by lifetime sales up to 2026, Projected top 10 pharmaceutical products worldwide based on lifetime sales as of 2026 (in billion U.S. dollars), COVID-19 vaccine dose numbers by top manufacturer 2021, Drug manufacturers with the highest number of ordered COVID-19 vaccine doses as of March 2021* (in million doses), Top companies by COVID-19 treatment vaccines in development June 2022, Leading companies by number of COVID-19 drugs and vaccines in development as of June 3, 2022, Number of COVID-19 drugs in development worldwide by phase June 2022, Number of coronavirus (COVID-19) drugs and vaccines in development worldwide as of June 3, 2022, by phase, BARDA funding for the development of COVID-19 vaccines in the U.S. 2021, BARDA funding for the development of COVID-19 vaccines in the United States as of March 2021* (in million U.S. dollars), Forecasted sales of select COVID-19 vaccines worldwide 2021-2022, Forecasted sales of select COVID-19 vaccines worldwide in 2021 and 2022 (in billion U.S. dollars), Gilead Science's remdesivir manufacturing projections 2020, Cumulative amount of remdesivir treatment courses projected to be manufactured by Gilead Sciences during 2020 (in 1,000s), Global mRNA vaccines and therapeutics market for COVID-19 Q4 2020 vs. 2025, Global mRNA vaccines and therapeutics market for COVID-19 in Q4 2020 and a forecast for Q4 2025 (in million U.S. dollars). After Brazil, Mexico is the second-largest pharmaceutical market in South America. Net annual sales = total sale by the company during the accounting period, Average working capital = (Working capital at the start of accounting period at the end of the accounting period) / 2, A high working capital turnover ratio indicates , A lower working capital turnover ratio indicates . Pfizer, Merck, and Johnson & Johnson are the top-ranking global pharmaceutical companies. A basic comparison of your company figures with those of your competitors will provide a quick insight into your business performance. The curation of data over 10 years makes it a go-to document for in-depth industry trends. This statistic lists the global pharmaceutical sales between 2010 and 2021. However, at times, a higher inventory ratio could also cause loss of sales as there is no inventory left to sell. Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. Once a pharmaceutical company manages to bring a product to market, a key element is how the company can manufacture and sell the product. The industry is trading at a PE ratio of 26.0x which is lower than its 3-year average PE of 46.5x. .a{fill:#6db41e;stroke:#637733;}.b,.d{fill:none;}.b{stroke:#fff;}.c{stroke:none;}, +899.62 (+1.53%) french open tsitsipas woolworths shareholder equity. If you have a Facebook or Twitter account, you can use it to log in to ReadyRatios: You can log in if you are registered at one of these services: This website uses cookies. Dollars of revenue. Financial Ratio This score has to be compared with competitors and industry benchmarks to make good sense of it. mcmarketstockprice->Moneycontrol/MC_Market/MC_Market_StockPrice_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_BTF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_BTF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250/MC_Market_StockPrice_Notices_300x250_ATF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_QuartResult_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_CapitalStruc_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_PriceChart_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_History_300x600_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_MTF->, Standard Medical Pharmaceuticals is not listed on BSE, Standard Medical Pharmaceuticals is not listed on NSE, Invest in high-rated bonds from as low as Rs. The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. The company develops and manufactures medicines and vaccines in a variety of medical fields, including oncology, neurology, cardiology, endocrinology, and immunology. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Key Financial Ratios for Airline Companies. %Non-Cash Expenses / Net Sales is a measure of the companys non-cash expenses to sales. Therefore, it is also helpful for investors to look at basic profitability ratios, such as operating margin and net margin. The Pharmaceutical Company has thus been increasing its net profit margin for the last three years, and therefore it is improving its efficiency in cost control. Home > PE Ratio > SUN PHARMACEUTICAL INDUSTRIES . if(typeof(wpDataCharts)=='undefined'){wpDataCharts = {};}; wpDataCharts[527] = {render_data: {"options":{"title":{"text":"World Pharmaceutical Sales by Region 2010-2021","floating":false,"align":"center"},"series":[{"type":"","name":"World total","color":"","label":"World total","orig_header":"worldtotal","data":[780000,799000,810000,759000,826000,906000,916000,930000,972000,1059000,1101000,1186000],"yAxis":0},{"type":"","name":"United States","color":"","label":"United States","orig_header":"unitedstates","data":[315000,329000,326000,328000,369000,416000,437000,440000,467000,493000,515000,555000],"yAxis":0},{"type":"","name":"Emerging markets","color":"","label":"Emerging markets","orig_header":"emergingmarkets","data":[152000,151000,168000,160000,168000,183000,185000,198000,199000,207000,255000,285000],"yAxis":0},{"type":"","name":"Europe","color":"","label":"Europe","orig_header":"europe","data":[181000,204000,206000,177000,179000,197000,182000,177000,192000,207000,216000,228000],"yAxis":0},{"type":"","name":"Established ROW","color":"","label":"Established ROW","orig_header":"establishedrow","data":[131000,113000,110000,94000,110000,109000,113000,112000,113000,115000,115000,118000],"yAxis":0}],"xAxis":{"categories":[2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021],"title":{"text":"Region"},"crosshair":false},"yAxis":[{"gridLineDashStyle":"solid","title":{"text":"Sales in Million US$"},"crosshair":false},[],[],[],[]],"chart":{"backgroundColor":"","borderWidth":0,"borderColor":"","borderRadius":0,"zoomType":"none","panning":false,"panKey":"shift","plotBackgroundColor":"","plotBackgroundImage":"","plotBorderColor":"","plotBorderWidth":"","inverted":false},"subtitle":{"text":"","align":"center"},"tooltip":{"enabled":true,"backgroundColor":"rgba(255,255,255,0.85)","borderWidth":"1","borderColor":"","borderRadius":3,"shared":false,"valuePrefix":"","valueSuffix":""},"legend":{"enabled":true,"backgroundColor":"","title":{"text":""},"layout":"horizontal","align":"center","verticalAlign":"bottom","borderWidth":"0","borderColor":"","borderRadius":"0"},"exporting":{"enabled":false,"chartOptions":{"plotOptions":{"series":{"dataLabels":{"enabled":false}}}},"filename":"","width":"","buttons":{"contextButton":{"align":"right","verticalAlign":"top","symbolStroke":"#666","text":""}}},"credits":{"enabled":true,"href":"https:\/\/market.us\/","text":"\u00a9 Market.us 2022"}},"type":"highcharts_basic_column_chart","height":"400"}, engine: "highcharts", type: "highcharts_basic_column_chart", title: "World Pharmaceutical Sales by Region 2010-2021", container: "wpDataChart_527", follow_filtering: 0, wpdatatable_id: 620, group_chart: 0}. Pfizer current ratio for the three months ending March 31, 2022 was 1.39. It does not store any personal data. ROI. If inventory levels are well managed by the company, it indicates that sales are as estimated and costs are controlled. The most important key figures provide you with a compact summary of the topic of "Global pharmaceutical industry" and take you straight to the corresponding statistics. A company's ROE is a valuable indicator of both how effectively the organization is utilizing its equity capital and how profitable the company is for equity investors. The price-to-book (P/B) ratio evaluates a firm's market value relative to its book value. It is otherwise also known as estimated price to earnings . The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Current ratio Quick ratio= Current assets/Current liabilities. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. This cookie is set by GDPR Cookie Consent plugin. Share Price 966.8: Mar 03,2023 . Explore now . Current ratio is a good tool for investors to measure a companys ability to repay their short-term debt with their current assets.